Meet BrosMed at MEDEXPO AFRICA 2022
Release time:
2022-02-10
BrosMed Medical will be attending the 23rd MEDEXPO AFRICA this year in Dar-es-Salaam, Tanzania. The event takes place at the Diamond Jubilee Expo Center on 17–19 February (Thurs, Fri, Sat), 2022.
BrosMed Medical will be attending the 23rd MEDEXPO AFRICA this year in Dar-es-Salaam, Tanzania.
The event takes place at the Diamond Jubilee Expo Center on 17–19 February (Thurs, Fri, Sat), 2022.
By visiting our booth at this exhibition, you will gain new insights into the BrosMed Medical’s wide range of interventional vascular specialties including Cardiovascular Intervention, Peripheral Intervention and Interventional Accessories.
Our Booth No. is B137 (Main Hall).
About BrosMed Medical
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), three manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 40 product series and 150+ products registration certificates in worldwide.
About MEDEXPO AFRICA 2022
The 23rd MEDEXPO 2022 – International Trade Exhibition is the largest trade event held annually in Tanzania. The exhibition attracts exhibitors from more than 20 countries and visitors from all over East & Central Africa, thus giving exhibitors an excellent opportunity to explore several countries at one time. Over the past few years, Tanzania has emerged as a major regional trade centre.
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
